Inventions & patents

Patent No. I359196:用於檢測伯氏疏螺旋體菌致病性菌株的引子對、檢驗套組以及方法Early detection of Borrelia burgdorferi sensu lato, the PCR primer pair and diagnostic method. (50%) 

Patent No. I580782: 去除陰電性低密度脂蛋白之生化反應材料與裝置以及體外處理血液或血漿以去除其中陰電性低密度脂蛋白的方法Biochemistry reactive material and device for eliminating low-density lipoprotein (LDL) and method for treating blood or plasma ex vivo to eliminate low-density lipoprotein therein (25%) (20170501~20350810)

Patent No. CN106434619B: 生化反应材料与装置以及体外处理血液或血浆的方法(25%) (20200324~20351123)

Patent No. US20170044516A1: Biochemistry reactive material and device for eliminating low-density lipoprotein (LDL) and method for treating blood or plasma ex vivo to eliminate low-density lipoprotein therein (25%) (20170216~20200130)

Patent No. US20150148410A1: Identification of specific apolipoprotein epitopes on circulating atherogenic LDL. WO/2013/036926 (50%) (20150528~)

Patent No. US20190010483A1 Method for ex vivo treating blood or plasma (25%) (20190110~)

Publications

Publications (*: corresponding author)

1. Chu PY, Huang HW, Boonchan M, Tyan YC, Louis KL, Lee KM, Motomura K*, Ke LY*. Mass Spectrometry-Based System for Identifying and Typing Norovirus Major Capsid Protein VP1. Viruses. 2021, 13(11), 2332 [IF=5.048]
2. Tsao CH, Hsieh WC, Yang RY, Lo YH, Tu TJ, Ke LY, Zouboulis CC, Liu FT. Galectin-12 modulates sebocyte proliferation and cell cycle progression by regulating cyclin A1 and CDK2. Glycobiology. 2021 Sep 24:cwab100. PMID: 34791227
3. Lin YS, Liu CK, Lee HC, Chou MC, Ke LY, Chen CH, Chen SL. Electronegative very-low-density lipoprotein induces brain inflammation and cognitive dysfunction in mice. Sci Rep. 2021 Mar 16;11(1):6013. 
4. Shin SJ, Chen CH, Kuo WC, Chan HC, Chan HCB, Lin KD, Ke LY*. Disruption of retinoid homeostasis induces RBP4 overproduction in diabetes: O-GlcNAcylation involved. Metabolism. 2020 Dec;113:154403. [IF=6.159; R/C=17/143=11.9% in ENDOCRINOLOGY & METABOLISM] PMID: 33065162
5. Ke LY†, Law SH†, Mishra VK, Parveen F, Chan HC, Lu YH, Chu CS*. Molecular and cellular mechanisms of electronegative lipoproteins in cardiovascular diseases. Biomedicines. 2020 Nov 29;8(12):550. [IF=4.717; R/C=36/270= 13.3% in PHARMACOLOGY & PHARMACY] PMID: 33260304.
6. Chan HC†, Ke LY†, Lu HT, Weng SF, Chan HC, Law SH, Lin IL, Chang CF, Lu YH, Chen CH, Chu CS*. An increased plasma level of apoCIII-rich electronegative high-density lipoprotein may contribute to cognitive impairment in Alzheimer's disease. Biomedicines 2020 Nov 26;8(12):542. [IF=4.717; R/C=36/270= 13.3% in PHARMACOLOGY & PHARMACY] PMID: 33256187.
7. Kakino A, Fujita Y, Ke LY, Chan HC, Tsai MH, Dai CY, Chen CH, Sawamura T. Adiponectin forms a complex with atherogenic LDL and inhibits its downstream effects. J Lipid Res. 2020 Nov 21;62:100001. [IF=4.483; R/C=78/297=26.3% in BIOCHEMISTRY & MOLECULAR BIOLOGY] PMID: 33410750.
8. Liang HL, Cheng PW, Lin HL, Hao CL, Ke LY, Chou HY, Tseng YH, Yen HW, Shen KP. Extract of pre-germinated brown rice protects against cardiovascular dysfunction by reducing levels of inflammation and free radicals in a rat model of type II diabetes. Journal of Functional Foods Dec 2020, 75, 104215 [IF=3.701; R/C=31/139=22.3% in FOOD SCIENCE & TECHNOLOGY]
9. Marathe GK, Chaithra VH, Ke LY, Chen CH. Effect of acyl and alkyl analogs of platelet-activating factor on inflammatory signaling. Prostaglandins Other Lipid Mediat. 2020 Dec;151:106478 [IF=2.283; R/C=207/297=69.7% in BIOCHEMISTRY & MOLECULAR BIOLOGY] PMID: 32711129
10. Lee HC, Shin SJ, Huang JK, Lin MY, Lin YH, Ke LY, Jiang HJ, Tsai WC, Chao MF, Lin YH. The role of postprandial very-low-density lipoprotein in the development of atrial remodeling in metabolic syndrome. Lipids Health Dis. 2020 Sep 22;19(1):210. [IF=2.906; R/C=166/297=55.9% in BIOCHEMISTRY & MOLECULAR BIOLOGY] PMID: 32962696.
11. Chu CS, Law SH, Lenzen D, Tan YH, Weng SF, Ito E, Wu JC, Chen CH, Chan HC*, Ke LY*. Clinical significance of electronegative low-density lipoprotein cholesterol in atherothrombosis. Biomedicines 2020 Jul 30;8(8):254. [IF=4.717; R/C=36/270= 13.3% in PHARMACOLOGY & PHARMACY] PMID: 32751498.
12. Ke LY*, Chan HC, Chen CC, Chang CF, Lu PL, Chu CS, Lai WT, Shin SJ, Liu FT, Chen CH*. Increased APOE glycosylation plays a key role in the atherogenicity of L5 low-density lipoprotein. FASEB J 2020 Jul;34(7):9802-9813. [IF=4.966; R/C=9/93=9.7% in BIOLOGY] PMID: 32501643.
13. Chan HC, Chan HCB, Liang CJ, Lee HC, Su H, Lee AS, Shiea J, Tsai WC, Ou TT, Wu CC, Chu CS, Dixon RA, Ke LY*, Yen JH*, and Chen CH*. Role of low-density lipoprotein in early vascular aging associated with systemic lupus erythematosus. Arthritis Rheumatol. 2020 Jun;72(6):972-984. [IF=9.586; R/C=3/32=9.4% in RHEUMATOLOGY] PMID: 31994323.
14. Chen CH, Ke LY, Chan HC, Chu CS, Lee AS, Lin KD, Lee MY, Hsiao PJ, Chen CH, Shin SJ. Electronegative low-density lipoprotein of patients with metabolic syndrome induces pathogenesis of aorta through disruption of the stimulated by retinoic acid 6 cascade. J Diabetes Investig. 2020 May;11(3):535-544. [IF=3.761; R/C=48/143=33.6% in ENDOCRINOLOGY & METABOLISM] PMID: 31597015.
15. Mishra VK†, Shih HH†, Parveen F, Lenzen D, Ito E, Chan TF*, Ke LY*. Identifying the therapeutic significance of mesenchymal stem cells. Cells 2020 May 6;9(5):1145. [IF=4.366; R/C=70/195=35.9% in CELL BIOLOGY] PMID: 32384763.
16. Lin HL, Lin SH, Shen KP, Chan HC, Tseng YH, Yen HW, Law SH, Ke LY*. Efficiency comparison of PGBR extract and γ-oryzanol in antioxidative stress and anti-inflammatory properties against metabolic syndrome. J Food Biochem. 2020 Feb;44(2):e13129. [IF=1.662; R/C=85/139=61.1% in FOOD SCIENCE AND TECHNOLOGY] PMID: 31846084.
17. Parveen F†, Bender D†, Law SH, Mishra VK, Chen CC, Ke LY*. Role of ceramidases in sphingolipid metabolism and human diseases. Cells. 2019 Dec 4;8(12):1573. [IF=5.656; R/C=40/193=20.7% in CELL BIOLOGY] PMID: 31817238.
18. Lia CL, Chu CH, Lee HC, Chou MC, Liu CK, Chen CH, Ke LY, Chen SL. Immunoregulatory effects of very low density lipoprotein from healthy individuals and metabolic syndrome patients on glial cells. Immunobiology 2019 Sep;224(5):632-637. [IF=2.798; R/C=96/158=60.8% in IMMUNOLOGY] PMID: 31402151.
19. Iha K, Inada M, Kawada N, Nakaishi K, Watabe S, Tan YH, Shen C, Ke LY, Yoshimura T, Ito E*. Ultrasensitive ELISA developed for early diagnosis. Diagnostics 2019 Jul 18; 9(3), pii: E78. [IF=2.489; R/C=46/160=28.4% in MEDICINE, GENERAL & INTERNAL] PMID: 31323782.
20. Shiou YL, Lin HT, Ke LY, Wu BN, Shin SJ, Chen CH, Tsai WC, Chu CS, Lee HC. Very low-density lipoproteins of metabolic syndrome modulates STIM1, suppresses store-operated calcium entry, and deranges myofilament proteins in atrial myocytes. J Clin Med. 2019 Jun 20;8(6):881. [IF=5.688; R/C=15/160=9.1% in MEDICINE, GENERAL & INTERNAL]. PMID: 31226824.
21. Chen CH, Lin KD, Ke LY, Liang CJ, Kuo WC, Lee MY, Lee YL, Hsiao PJ, Hsu CC, Shin SJ. O-GlcNAcylation disrupts STRA6-retinol signals in kidneys of diabetes. Biochim Biophys Acta-Gen Subj. 2019 Jun;1863(6):1059-1069. [IF=3.681; R/C=19/72=25.7% in BIOPHYSICS]. PMID: 30905621.
22. Yamakado S, Cho H, Inada M, Morikawa M, Jiang YH, Saito K, Nakaishi K, Watabe S, Takagi H, Kaneda M, Nakatsuma A, Ninomiya M, Imachi H, Arai T, Yoshimoto T, Murao K, Chang JH, Chen SM, Shih YC, Zeng MJ , Ke LY, Chen CH, Yoshimura T, Miura T, Ito E*. Urinary Adiponectin as A New Diagnostic Index for Chronic Kidney Disease Due to Diabetic Nephropathy. BMJ Open Diabetes Research & Care 2019 May 30;7(1):e000661. [IF=5.067; R/C=24/145=16.6% in ENDOCRINOLOGY & METABOLISM] PMID: 31245009.
23. Chen FC, Shen KP, Ke LY, Lin HL, Wu CC, Shaw SU*. Flavonoids from Camellia sinensis (L.) O. Kuntze seed ameliorates TNF-a induced insulin resistance in HepG2 cells, Saudi Pharm J. 2019 May;27(4):507-516. [IF=3.643; R/C=65/267=24.3% in PHARMACOLOGY & PHARMACY]. PMID: 31061619
24. Law SH†, Chan ML†, Marathe GK, Parveen F, Chen CH, Ke LY*. An updated review of lysophosphatidylcholine metabolism in human diseases. Int J Mol Sci. 2019 Mar 6;20(5):1149. [IF=4.183; 78/298=26.0% in BIOCHEMISTRY & MOLECULAR BIOLOGY]. PMID: 30845751.
25. Hao CL, Lin HL, Ke LY, Yen HW, Shen KP*. Pre‐germinated brown rice extract ameliorates high‐fat diet‐induced metabolic syndrome. J Food Biochem. 2019 Mar;43(3):e12769. [IF=1.552; R/C=75/133=56.4% in FOOD SCIENCE & TECHNOLOGY]. PMID: 31353547.
26. Chu CS†, Chan HC†, Tsai MH, Stancel N, Lee HC, Cheng KH, Tung YC, Chan HCB, Wang CY, Shin SJ, Lai WT, Yang CY, Dixon RA, Chen CH*, Ke LY*. Range of L5 LDL levels in healthy adults and L5’s predictive power in patients with hyperlipidemia or coronary artery disease. Sci Rep. 2018 Aug 8;8(1):11866. [IF=4.122; 12/64=18.8 % in MULTIDISCIPLINARY SCIENCES] PMID: 30089847.
27. Wang YC†, Lee AS†, Lu LS†, Ke LY, Chen WY, Dong JW, Lu J, Chen ZP, Chu CS, Chan HC, Kuzan TY, Tsai MH, Hsu WL, Dixon RAF, Sawamura T, Chang KC*, Chen CH*. Human electronegative LDL induces mitochondrial dysfunction and premature senescence of vascular cells in vivo. Aging Cell. 2018 Aug;17(4):e12792. [IF=7.627; 3/53=5.7 % in GERIATRICS & GERONTOLOGY]
28. Lee CH, Chu CS, Tsai HJ, Ke LY, Lee HC, Yeh JL, Chen CH, Wu BN. Xanthine- derived KMUP-1 reverses glucotoxicity-activated Kv channels through the cAMP/PKA signaling pathway in rat pancreatic β cells. Chem Biol Interact. 2018 Jan 5;279:171-176.
29. Ke LY, Chan HC, Chan HCB, Kalu FCU, Lee HC, Lin IL, Jhuo SJ, Lai WT, Tsao CR, Sawamura T, Dixon RA, Chen CH, Chu CS*, Shin SJ*. Electronegative low-density lipoprotein L5 induces adipose tissue inflammation associated with metabolic syndrome. J Clin Endocrinol Metab 2017 Dec 1;102(12):4615- 4625. [IF=5.455; R/C=20/138=14.5% in ENDOCRINOLOGY & METABOLISM].
30. Akyol S*, Lu J, Akyol O, Akcay F, Armutcu F, Ke LY*, Chen CH. The role of electronegative low-density lipoprotein in cardiovascular diseases and its therapeutic implications. Trends in Cardiovasc Med. 2017 May;27(4):239-246. [IF=4.964; R/C=25/126=19.8% in CARDIAC AND CARDIOVASCULAR SYSTEMS].
31. Ke LY, Chang JG, Chang CS, Hsieh LL, Liu TC. Rapid screening for deleted form β-thalassemia by real-time quantitative PCR. J Clin Lab Anal. 2017 Jan;31(1). doi: 10.1002/jcla.22019. Epub 2016 Aug 16.
32. Chu CS, Ke LY, Chan HC, Chan HCB, Chen CC, Cheng KC, Lee HC, Kuo HF, Chang CT, Sheu SH, Chen CH, Lai WT. The Four Statin Benefit Groups Defined by The 2013 ACC/AHA New Cholesterol Guideline are Characterized by Increased Plasma Level of Electronegative LDL. Acta Cardiol Sin. 2016 Nov;32(6):667-675.
33. Chen CH, Ke LY, Chan HC, Lee AS, Lin KD, Chu CS, Lee MY, Hsiao PJ, Hsu C, Chen CH*, Shin SJ*. Electronegative low-density lipoprotein induces renal apoptosis and fibrosis: STRA6 signaling involved. J Lipid Res. 2016 Aug;57(8):1435-46. [IF=4.810; R/C=54/286=18.9% in BIOCHEMISTRY MOLECULAR BIOLOGY].
34. Ke LY†, Chan HC†, Chen CC, Lu J, Marathe GK, Chu CS, Chan HC, Wang CY, Tung YC, McIntyre TM, Yen JH*, Chen CH*. Enhanced sphingomyelinase activity in apolipoprotein B100 contributes to the atherogenicity of electronegative LDL. J Med Chem. 2016 Feb 11;59(3):1032-40. [IF=6.259; R/C=3/60=5% in CHEMISTRY, MEDICINAL]
35. Lee HC, Lin HT, Ke LY, Wei C, Hsiao YL, Chu CS, Lai WT, Shin SJ, Chen CH, Sheu SH, Wu BN. VLDL from metabolic syndrome individuals enhanced lipid accumulation in atria with association of susceptibility to atrial fibrillation. Int J Mol Sci. 2016 Jan 20;17(1). 
36. Stancel N, Chen CC, Ke LY, Chu CS, Lu J, Sawamura T, Chen CH*. Interplay between CRP, atherogenic LDL, and LOX-1 and its potential role in the pathogenesis of atherosclerosis. Clin Chem. 2016 Feb;62(2):320-7. PMID: 26607724. [IF=8.008; R/C=1/30=3.3% in MEDICAL LABORATORY TECHNOLOGY]
37. Tung YC, Ke LY, Lu PL, Lin KH, Lee SC, Lin YY, Chou LC, Tsai WC. Comparison of the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test v1.0 with v2.0 in HIV-1 viral load quantification. Kaohsiung J Med Sci. 2015 Apr;31(4):188-93.
38. Tung YC, Ke LY, Tsai WC, Lin KH, Tsai SM, Wang CF, Lee HF, Su HJ, Lu PL. The development of a beacon-based real-time PCR for cytomegalovirus and its application in immunocompromised patients. Clin Lab. 2014;60(11):1895-901.
39. Ke LY†, Stancel N†, Bair H, Chen CH*. The underlying chemistry of electronegative LDL’s atherogenicity. Curr Atheroscler Rep. 2014;16:428. [IF=2.731; R/C=35/63=55.5% in PERIPHERAL VASCULAR DISEASE]
40. Tung YC, Ke LY, Tsai SM, Lu PL, Tsai WC. High seroprevalence of human herpesvirus 8 infection in patients with systemic lupus erythematosus. Int J Rheum Dis. 2013 Dec;16(6):709-14.
41. Chan HC†, Ke LY† (co-first), Chu CS, Lee AS, Shen MY, Cruz MA, Hsu JF, Cheng KH, Chan HC, Lu J, Lai WT, Sawamura T, Sheu SH, Yen JH*, Chen CH*. Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation. Blood. 2013;122:3632-3641. [IF=13.164; R/C=2/70=2.9% in CARDIAC & CARDIOVASCULAR SYSTEMS] 
42. Tung YC, Lu PL, Ke LY, Tsai WC. CMV Infection and Pregnancy. Curr Obstet Gynecol Rep (2012) 1:216-222; 1(4). DOI:10.1007/s13669-012-0028-1.
43. Ke GM, Lin KH, Lu PL, Tung YC, Wang CF, Ke LY, Lee MS, Lin PC, Su HJ, Lin YY, Huang TP, Wang JR, Wang SY, Hsu LC, Chu PY. Molecular epidemiology of Echovirus 30 in Taiwan, 1988-2008. Virus Genes. 2011 Apr;42(2):178-88.
44. Ke LY, Engler DA, Lu J, Matsunami RK, Chan HC, Wang GJ, Yang CY, Chang JG, Chen CH*. Chemical composition–oriented receptor selectivity of L5, a naturally occurring atherogenic low-density lipoprotein. Pure Appl Chem. 2011;83:1731-1740. PMID: 24198440. [IF=2.626; R/C=67/166=40.3% in CHEMISTRY, MULTIDISCIPLINARY]
45. Chan HC, Ke LY, Liu CC, Chang LL, Tsai WC, Liu HW, Yen JH. Increased expression of suppressor of cytokine signaling 1 mRNA in patients with rheumatoid arthritis. Kaohsiung J Med Sci. 2010 Jun;26(6):290-8.
46. Chan HC, Ke LY, Chang LL, Liu CC, Hung YH, Lin CH, Li RN, Tsai WC, Liu HW, Yen JH. Suppressor of cytokine signaling 1 gene expression and polymorphisms in systemic lupus erythematosus. Lupus. 2010 May;19(6):696-702.
47. Ke GM, Yu SW, Ho CH, Chu PY, Ke LY, Lin KH, Tsai YC, Liu HJ, Lin MY. Characterization of newly emerging Newcastle disease viruses isolated during 2002-2008 in Taiwan. Virus Res. 2010 Feb;147(2):247-57.
48. Chu PY, Ke GM, Chang CH, Lin JC, Sun CY, Huang WL, Tsai YC, Ke LY, Lin KH. Molecular epidemiology of coxsackie A type 24 variant in Taiwan, 2000-2007. J Clin Virol. 2009 Aug;45(4):285-91.
49. Chen CH, Dixon RAF, Ke LY, Willerson JT. Vascular progenitor cells in diabetes mellitus: Roles of Wnt signaling and negatively charged LDL. Circ Res. 2009;104:1038-1040. PMID:19423862. [IF=13.965; R/C=5/126=4.0% in CARDIAC AND CARDIOVASCULAR SYSTEMS].
50. Tung YC, Lin KH, Chiang HC, Ke LY, Chen YH, Ke GM, Chen TC, Chou LC, Lu PL. Molecular epidemiology of dengue virus serotype 2 in the Taiwan 2002 outbreak with envelope gene and nonstructural protein 1 gene analysis. Kaohsiung J Med Sci. 2008 Aug;24(8):398-407.
51. Tung YC, Lin KH, Chang K, Ke LY, Ke GM, Lu PL, Lin CY, Chen YH, Chiang HC. Phylogenetic study of dengue-3 virus in Taiwan with sequence analysis of the core gene. Kaohsiung J Med Sci. 2008 Feb;24(2):55-62.
52. Tsai JJ, Sun HY, Ke LY, Tsai KS, Chang SY, Hsieh SM, Hsiao CF, Yen JH, Hung CC, Chang SC. Higher seroprevalence of Entamoeba histolytica infection is associated with human immunodeficiency virus type 1 infection in Taiwan. Am J Trop Med Hyg. 2006 Jun;74(6):1016-9.
53. Ke GM, Cheng HL, Ke LY, Ji WT, Chulu JL, Liao MH, Chang TJ, Liu HJ. Development of a quantitative Light Cycler real-time RT-PCR for detection of avian reovirus. J Virol Methods. 2006 Apr;133(1):6-13.
54. Hsu MC, Tsai PY, Chen KT, Li LH, Chiang CC, Tsai JJ, Ke LY, Chen HY, Li SY. Genotyping of Chlamydia trachomatis from clinical specimens in Taiwan. J Med Microbiol. 2006 Mar;55(Pt 3):301-8.
55. Lin KH, Hwang KP, Ke GM, Wang CF, Ke LY, Hsu YT, Tung YC, Chu PY, Chen BH, Chen HL, Kao CL, Wang JR, Eng HL, Wang SY, Hsu LC, Chen HY. Evolution of EV71 genogroup in Taiwan from 1998 to 2005: an emerging of subgenogroup C4 of EV71. J Med Virol. 2006 Feb;78(2):254-62.

2022 Activities

20220611 Graduation ceremony

2021 Activities

20211016 40th ann

20211015 Special talks by Professor Guenter Schwarz from Cologne University, Germany. Topics: Molybdenum cofactor deficiency: The journey of finding a treating for a rare inborn error in metabolism  

20211015 Special talks by Ph.D. cadidate CY Fu from Cologne University, Germany. Topics: Metabolic interaction of systeine dioxygenase and sulfite oxidase in systeine catabolism

20210625 Special talks by Professor Gopal K. Marathe from Mysore University, India. Topics: Effect of acyl and alkyl analogs of platelet-activating factor on inflammatory signaling

20210624 Special talks by Professor Gopal K. Marathe from Mysore University, India. Topics: Different glycoforms of alpha-1-acid glycoprotein contribute to its functional alterations in platelets and neutrophils

20210301~05 Liang-Yin Ke gave a talk at the 9th International Singapore Lipid Symposium – Lipid Oxidation Section. Topics: Specifying the Clinical Significance of Electronegative Low-density Lipoprotein in Atherothrombosis. The organizer of this event was Prof. Markus R Wenk from the National University of Singapore, Singapore.

20210219 Liang-Yin Ke gave a talk “Atherosclerosis and electronegative LDL” to Professor Gopal K Marathe, Mysore University, India.

2020 Activities

20201120 Shi Hui Law's Lightening talk for session three Virtual podium Asia pacific - metabolomics and lipidomics

20201113 Yong Hong Tan's Lightening talk for session two Virtual podium Asia pacific - metabolomics and lipidomics

20201030 舉辦「應用質譜科技於精準醫學工作坊」，專家演講講題為高解析質譜儀(Q-TOF)在臨床醫學上的應用；講者 : 詹華蓁、江佳穎

2019 Activities

20190601 Graduate ceremony

20190129 Professor Schwarz

20190129 Professor Lu

20190129 Professor Marathe

20190128 Professor Schwarz

20190110 BioTech Final Presentation

2018 Activities

20181227 Professor Ito

20181119 Daniel from Cologne University

20181009~12 BCS2018

20181003-20181007 Abisko, Kiruna

20180817~20180921 Cologne U

20180726~20180831 Waseda U

20180708 Gopal教授、蕭明熙教授、張權發教授蒞校演講

20180118~20180209 Cologne U, Germany

2017 Activities

20171222 International students

Labroatory Members

Labroatory Members

Ph.D. Students: 劉思慧 Shi Hui Law, Ching-Han Tsao 

Master Students: 陳依蓓 I-Pei Chen, 蔡馨儀, 吳佳盈, 洪紹旂 Hung Shao-Chi

Bachelor Students:

Graduate

(畢業) Master Students: Hsiao-Ting Lu, Huang Shih-Han, Shi Hui Law, Liu-Fang Wang, Yong Hong Tan, Bo-Xuan Yao

202206 Hung Shao-Chi

202106 Liu-Fang Wang, Yong Hong Tan

20200605 David Lenzen,

1. Chu CS, Law SH, Lenzen D, Tan YH, Weng SF, Ito E, Wu JC, Chen CH, Chan HC, Ke LY. Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis. Biomedicines. 2020 Jul 30;8(8):254. doi: 10.3390/biomedicines8080254. PMID: 32751498
2. Mishra VK, Shih HH, Parveen F, Lenzen D, Ito E, Chan TF, Ke LY. Identifying the Therapeutic Significance of Mesenchymal Stem Cells. Cells. 2020 May 6;9(5):1145. doi: 10.3390/cells9051145. PMID: 32384763

20190601 Shi Hui Law, Yong Hong Tan, Chieh Shen

1. Parveen F, Bender D, Law SH, Mishra VK, Chen CC, Ke LY. Role of Ceramidases in Sphingolipid Metabolism and Human Diseases. Cells. 2019 Dec 4;8(12):1573. doi: 10.3390/cells8121573. PMID: 31817238
2. Law SH, Chan ML, Marathe GK, Parveen F, Chen CH, Ke LY. An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases. Int J Mol Sci. 2019 Mar 6;20(5):1149. doi: 10.3390/ijms20051149. PMID: 30845751 
3. Iha K, Inada M, Kawada N, Nakaishi K, Watabe S, Tan YH, Shen C, Ke LY, Yoshimura T, Ito E. Ultrasensitive ELISA Developed for Diagnosis. Diagnostics (Basel). 2019 Jul 18;9(3):78. doi: 10.3390/diagnostics9030078. PMID: 31323782

 20180608 Jyun-Hao Chang, Shih-Min Chen, Yi-Chen Shih, Min-Jing Zeng

1. Yamakado S, Cho H, Inada M, Morikawa M, Jiang YH, Saito K, Nakaishi K, Watabe S, Takagi H, Kaneda M, Nakatsuma A, Ninomiya M, Imachi H, Arai T, Yoshimoto T, Murao K, Chang JH, Chen SM, Shih YC, Zeng MJ, Ke LY, Chen CH, Yoshimura T, Miura T, Ito E. Urinary adiponectin as a new diagnostic index for chronic kidney disease due to diabetic nephropathy. BMJ Open Diabetes Res Care. 2019 May 30;7(1):e000661. doi: 10.1136/bmjdrc-2019-000661.

20170610 commencement